HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment

Documenti analoghi

• Transfusion‐transmissible coinfections among US blood donors
  di: Galen Conti, et al.
  Pubblicazione: (2024)
• Urban versus rural blood donors in the United States and the relationship with transfusion‐transmissible infections
  di: Galen Conti, et al.
  Pubblicazione: (2025)
• Factors associated with HIV infection in U.S. blood donors across evolving deferral policies
  di: Vivian I. Avelino‐Silva, et al.
  Pubblicazione: (2025)
• Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion‐transmissible infections monitoring system
  di: Emilya Huseynova, et al.
  Pubblicazione: (2025)
• Syphilis seroprevalence and incidence in US blood donors from 2020 to 2022
  di: Galen Conti, et al.
  Pubblicazione: (2024)